Literature DB >> 15365034

Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico.

Nahum Méndez-Sánchez1, Daniel Motola-Kuba, Norberto C Chavez-Tapia, Jesús Bahena, Ricardo Correa-Rotter, Misael Uribe.   

Abstract

We determined the prevalence of hepatitis C virus (HCV) in hemodialysis patients by antibody testing and HCV RNA determination by PCR. A total of 149 patients with kidney failure with replacement therapy were tested. The prevalence of anti-HCV was 6.7% (10 of 149 patients), and viremia was detectable in 8 of 149 (5%) patients. Three of 149 patients (2%) were anti-HCV negative with detectable HCV RNA.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15365034      PMCID： PMC516306          DOI： 10.1128/JCM.42.9.4321-4322.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  24 in total

1.  Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis.

Authors:  N Petrosillo; P Gilli; D Serraino; P Dentico; A Mele; P Ragni; V Puro; C Casalino; G Ippolito
Journal:  Am J Kidney Dis       Date:  2001-05       Impact factor: 8.860

2.  Hepatitis C screening strategies in hemodialysis patients.

Authors:  S Saab; M Brezina; G Gitnick; P Martin; H F Yee
Journal:  Am J Kidney Dis       Date:  2001-07       Impact factor: 8.860

Review 3.  Hepatitis C.

Authors:  A M Di Bisceglie
Journal:  Lancet       Date:  1998-01-31       Impact factor: 79.321

4.  Biological dynamics of viral load in hemodialysis patients with hepatitis C virus.

Authors:  F Fabrizi; P Martin; V Dixit; M Brezina; M J Cole; S Vinson; M Mousa; G Gitnick
Journal:  Am J Kidney Dis       Date:  2000-01       Impact factor: 8.860

5.  [Viral C hepatitis in patients with end stage renal disease. II. Viral genotypes].

Authors:  L González-Michaca; A Mercado; G Gamba
Journal:  Rev Invest Clin       Date:  2000 Sep-Oct       Impact factor: 1.451

6.  Serotyping strip immunoblot assay for assessing hepatitis C virus strains in dialysis patients.

Authors:  F Fabrizi; P Martin; S Quan; V Dixit; M Brezina; A Conrad; A Polito; G Gitnick
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

7.  Lack of seronegative hepatitis C virus infections in patients with chronic renal failure.

Authors:  Violet A Kelley; Jennifer Everett-Kitchens; Laura E Brannon; Kathleen Connor; Enrique J Martinez; Thomas C Pearson; Frederick S Nolte
Journal:  Transplantation       Date:  2002-11-27       Impact factor: 4.939

8.  Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients.

Authors:  H Hinrichsen; G Leimenstoll; G Stegen; H Schrader; U R Fölsch; W E Schmidt
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Characteristics of hepatitis C in renal transplant candidates.

Authors:  Scott J Cotler; Gloria Diaz; Sushama Gundlapalli; Shiram Jakate; Anshuman Chawla; Deepak Mital; Steven Jensik; Donald M Jensen
Journal:  J Clin Gastroenterol       Date:  2002-08       Impact factor: 3.062

10.  Absence of HCV viraemia in anti-HCV-negative haemodialysis patients.

Authors:  G N Dalekos; D S Boumba; K Katopodis; E Zervou; G Sferopoulos; M Elisaf; E V Tsianos; K C Siamopoulos
Journal:  Nephrol Dial Transplant       Date:  1998-07       Impact factor: 5.992
View more
  8 in total

1.  Incidence of CMV-HCV coinfection in renal transplant recipient.

Authors:  Avirup Chakraborty; Krishna Patil; Sanjay Dasgupta; Abhijit Tarafdar; Sekhar Chakrabarti; Nilanjan Chakraborty
Journal:  BMJ Case Rep       Date:  2012-04-02

2.  Micro-elimination of Hepatitis C in Low- and Middle-Income Settings: Challenges and Windows of Opportunity.

Authors:  Enrique Wolpert Barraza; David Kershenobich Stalnikowitz; Jorge Enrique Guerrero Guerrero; Alethse de la Torre Rosas
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-08-10

3.  A shield against a monster: Hepatitis C in hemodialysis patients.

Authors:  Seyed-Moayed Alavian
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

Review 4.  Management of hepatitis C virus infection in hemodialysis patients.

Authors:  Yue-Cheng Yu; Yue Wang; Chang-Lun He; Mao-Rong Wang; Yu-Ming Wang
Journal:  World J Hepatol       Date:  2014-06-27

5.  Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S.

Authors:  Emily Faye White; Richard S Garfein; Kimberly C Brouwer; Remedios Lozada; Rebeca Ramos; Michelle Firestone-Cruz; Saida G Pérez; Carlos Magis-Rodríguez; Carlos J Conde-Glez; Steffanie A Strathdee
Journal:  Salud Publica Mex       Date:  2007 May-Jun

6.  A cross sectional study of the risk factors of hepatitis C infection in North Egypt.

Authors:  Soad S Mandoh; Kholoud Ayman; Ahmed Elbardakheny; Hala Raaft; Ahmed A Ibrahim; Rasha Alsaeed Alshaikh; Fotouh R Mansour
Journal:  Virusdisease       Date:  2021-03-20

7.  Epidemiology of hepatitis C virus (HCV) infection.

Authors:  Theodore Sy; M Mazen Jamal
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

8.  Hepatitis B and C in dialysis units in Kosova.

Authors:  Skender Telaku; Hajrullah Fejza; Ymer Elezi; Teuta Bicaj
Journal:  Virol J       Date:  2009-06-04       Impact factor: 4.099
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.